| Year |
Citation |
Score |
| 2000 |
HOLLISTER LE. Allergic reactions to tranquilizing drugs. Annals of Internal Medicine. 49: 17-29. PMID 13545730 DOI: 10.7326/0003-4819-49-1-17 |
0.324 |
|
| 2000 |
HOLLISTER LE. Unexpected asphyxial death and tranquilizing drugs. The American Journal of Psychiatry. 114: 366-7. PMID 13458504 DOI: 10.1176/Ajp.114.4.366 |
0.305 |
|
| 1998 |
HOLLISTER LE. Drugs in emotional disorders: past and present. Annals of Internal Medicine. 51: 1032-48. PMID 14402699 DOI: 10.7326/0003-4819-51-5-1032 |
0.301 |
|
| 1998 |
HOLLISTER LE, BENNETT JL, KAIM SC, KIMBALL I. Drug-induced EEG abnormalities as predictors of clinical response to thiopropazate and haloperidol. The American Journal of Psychiatry. 119: 887-8. PMID 13961353 DOI: 10.1176/Ajp.119.9.887 |
0.327 |
|
| 1998 |
HOLLISTER LE, HARTMAN AM. Mescaline, lysergic acid diethylamide and psilocybin comparison of clinical syndromes, effects on color perception and biochemical measures. Comprehensive Psychiatry. 3: 235-42. PMID 13908449 DOI: 10.1016/S0010-440X(62)80024-8 |
0.362 |
|
| 1998 |
CASEY JF, LASKY JJ, KLETT CJ, HOLLISTER LE. Treatment of schizophrenic reactions with phenothiazine derivatives. A comparative study of chlorpromazine, triflupromazine, mepazine, prochlorperazine, perphenazine, and phenobarbital. The American Journal of Psychiatry. 117: 97-105. PMID 13808146 DOI: 10.1176/Ajp.117.2.97 |
0.323 |
|
| 1998 |
CASEY JF, BENNETT IF, LINDLEY CJ, HOLLISTER LE, GORDON MH, SPRINGER NN. Drug therapy in schizophrenia. A controlled study of the relative effectiveness of chlorpromazine, promazine, phenobarbital, and placebo. A.M.a. Archives of General Psychiatry. 2: 210-20. PMID 13808145 DOI: 10.1001/Archpsyc.1960.03590080086012 |
0.342 |
|
| 1998 |
CASEY JF, HOLLISTER LE, KLETT CJ, LASKY JJ, CAFFEY EM. Combined drug therapy of chronic schizophrenics. Controlled evaluation of placebo, dextro-amphetamine, imipiramine, isocarboxazid and trifluoperazine added to maintenance doses of chlorpromazine. The American Journal of Psychiatry. 117: 997-1003. PMID 13691268 DOI: 10.1176/Ajp.117.11.997 |
0.357 |
|
| 1996 |
HOLLISTER LE. NERVOS SYSTEM REACTIONS TO DRUGS. Annals of the New York Academy of Sciences. 123: 342-53. PMID 14329216 DOI: 10.1111/J.1749-6632.1965.Tb12275.X |
0.302 |
|
| 1996 |
KIMBELL I, OVERALL JE, HOLLISTER LE. ANTIDEPRESSANT DRUGS: MYTH OR REALITY? The Journal of New Drugs. 5: 9-12. PMID 14283070 DOI: 10.1002/J.1552-4604.1965.Tb00217.X |
0.342 |
|
| 1996 |
HOLLISTER LE, OVERALL JE, BENNETT JL, KIMBELL I, SHELTON J. TRIPERIDOL IN SCHIZOPHRENIA: FURTHER EVIDENCE FOR SPECIFIC PATTERNS OF ACTION OF ANTIPSYCHOTIC DRUGS. The Journal of New Drugs. 5: 34-42. PMID 14283066 DOI: 10.1002/J.1552-4604.1965.Tb00220.X |
0.305 |
|
| 1996 |
HOLLISTER LE, KANTER SL. STUDIES OF DELAYED-ACTION MEDICATION. IV. SALICYLATES. Clinical Pharmacology and Therapeutics. 6: 5-11. PMID 14253285 DOI: 10.1002/Cpt1965615 |
0.344 |
|
| 1996 |
HOLLISTER LE. ADVERSE REACTIONS TO DRUGS. Postgraduate Medicine. 37: 94-9. PMID 14220395 DOI: 10.1080/00325481.1965.11695403 |
0.311 |
|
| 1996 |
HOLLISTER LE. COMPLICATIONS FROM PSYCHOTHERAPEUTIC DRUGS--1964. Clinical Pharmacology and Therapeutics. 5: 322-33. PMID 14168522 DOI: 10.1002/Cpt196453322 |
0.321 |
|
| 1996 |
OVERALL JE, HOLLISTER LE, MEYER F, KIMBELL I, SHELTON J. IMIPRAMINE AND THIORIDAZINE IN DEPRESSED AND SCHIZOPHRENIC PATIENTS. ARE THERE SPECIFIC ANTIDEPRESSANT DRUGS? Jama. 189: 605-8. PMID 14162573 DOI: 10.1001/Jama.1964.03070080011002 |
0.32 |
|
| 1996 |
HOLLISTER LE. ADVERSE REACTIONS TO PHENOTHIAZINES. Jama. 189: 311-3. PMID 14160497 DOI: 10.1001/Jama.1964.03070040061014 |
0.364 |
|
| 1996 |
HOLLISTER LE, SJOBERG BM. CLINICAL SYNDROMES AND BIOCHEMICAL ALTERATIONS FOLLOWING MESCALINE, LYSERGIC ACID DIETHYLAMIDE, PSILOCYBIN AND A COMBINATION OF THE THREE PSYCHOTOMIMETIC DRUGS. Comprehensive Psychiatry. 5: 170-8. PMID 14156873 DOI: 10.1016/S0010-440X(64)80030-4 |
0.367 |
|
| 1993 |
Hollister LE. The Development of American Pharmacology: John J. Abel and the Shaping of a Discipline Jama: the Journal of the American Medical Association. 270: 98. DOI: 10.1001/Jama.1993.03510010104043 |
0.3 |
|
| 1991 |
Hollister LE. AMA Drug Evaluations Annual 1991 Jama: the Journal of the American Medical Association. 266: 424. DOI: 10.1001/Jama.1991.03470030126039 |
0.338 |
|
| 1988 |
Csernansky JG, Tacke U, Rusen D, Hollister LE. The effect of benzodiazepines on tardive dyskinesia symptoms. Journal of Clinical Psychopharmacology. 8: 154-5. PMID 3372715 DOI: 10.1097/00004714-198804000-00028 |
0.463 |
|
| 1988 |
Csernansky JG, Riney SJ, Lombrozo L, Overall JE, Hollister LE. Double-blind comparison of alprazolam, diazepam, and placebo for the treatment of negative schizophrenic symptoms. Archives of General Psychiatry. 45: 655-9. PMID 3289523 DOI: 10.1001/Archpsyc.1988.01800310063008 |
0.455 |
|
| 1988 |
Prosser ES, Csernansky JG, Hollister LE. Differences in the time course of haloperidol-induced up-regulation of rat striatal and mesolimbic dopamine receptors. Life Sciences. 43: 715-20. PMID 2901023 DOI: 10.1016/0024-3205(88)90143-9 |
0.488 |
|
| 1987 |
Beauclair L, Vinogradov S, Riney SJ, Csernansky JG, Hollister LE. An adjunctive role for ascorbic acid in the treatment of schizophrenia? Journal of Clinical Psychopharmacology. 7: 282-3. PMID 3624518 DOI: 10.1097/00004714-198708000-00037 |
0.452 |
|
| 1987 |
Finnegan KT, Terwilliger MM, Berger PA, Hollister LE, Csernansky JG. A comparison of the neurochemical and behavioral effects of clenbuterol and desipramine. European Journal of Pharmacology. 134: 131-6. PMID 3032650 DOI: 10.1016/0014-2999(87)90158-0 |
0.467 |
|
| 1987 |
Prosser ES, Csernansky JG, Kaplan J, Thiemann S, Becker TJ, Hollister LE. Depression, parkinsonian symptoms, and negative symptoms in schizophrenics treated with neuroleptics. The Journal of Nervous and Mental Disease. 175: 100-5. PMID 2879880 DOI: 10.1097/00005053-198702000-00006 |
0.503 |
|
| 1986 |
Csernansky JG, Csernansky CA, King R, Hollister LE. Oscillations in apomorphine-induced stereotypies during 1 year of apomorphine administration. Biological Psychiatry. 21: 402-5. PMID 3955116 DOI: 10.1016/0006-3223(86)90170-8 |
0.452 |
|
| 1986 |
Csernansky JG, Csernansky CA, Mellentin JD, Hollister LE. Carbamazepine and dopaminergic supersensitivity. Biological Psychiatry. 21: 238-9. PMID 3947704 DOI: 10.1016/0006-3223(86)90159-9 |
0.46 |
|
| 1986 |
Peabody CA, Whiteford HA, Hollister LE. Antidepressants and the elderly. Journal of the American Geriatrics Society. 34: 869-74. PMID 3537094 DOI: 10.1111/J.1532-5415.1986.Tb07261.X |
0.305 |
|
| 1986 |
Hollister LE. Drug therapy of Alzheimer's disease: realistic or not? Progress in Neuro-Psychopharmacology & Biological Psychiatry. 10: 439-46. PMID 3025926 DOI: 10.1016/0278-5846(86)90017-5 |
0.359 |
|
| 1986 |
Csernansky JG, Vinogradov S, Prosser E, Kaplan J, Berger PA, Hollister LE. Associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated schizophrenics: relevance to supersensitivity psychosis. Psychopharmacology Bulletin. 22: 897-9. PMID 2879311 |
0.397 |
|
| 1986 |
Csernansky JG, Prosser E, Kaplan J, Mahler E, Berger PA, Hollister LE. Possible associations among plasma prolactin levels, tardive dyskinesia, and paranoia in treated male schizophrenics. Biological Psychiatry. 21: 632-42. PMID 2871874 DOI: 10.1016/0006-3223(86)90124-1 |
0.495 |
|
| 1986 |
Hollister LE. Old and new approaches to drug treatment of schizophrenia Drug Development Research. 9: 9-21. DOI: 10.1002/Ddr.430090104 |
0.37 |
|
| 1985 |
Csernansky JG, Csernansky CA, Hollister LE. 3[H]-Sulpiride labels mesolimbic non-dopaminergic sites that bind antidepressant drugs. Experientia. 41: 1419-21. PMID 4065296 DOI: 10.1007/Bf01950013 |
0.45 |
|
| 1985 |
Csernansky JG, Csernansky CA, Bonnet KA, Hollister LE. Dopaminergic supersensitivity follows ferric chloride-induced limbic seizures. Biological Psychiatry. 20: 723-33. PMID 4039950 DOI: 10.1016/0006-3223(85)90151-9 |
0.466 |
|
| 1985 |
Magliozzi JR, Gillespie H, Lombrozo L, Hollister LE. Mood alteration following oral and intravenous haloperidol and relationship to drug concentration in normal subjects. Journal of Clinical Pharmacology. 25: 285-90. PMID 4008674 DOI: 10.1002/J.1552-4604.1985.Tb02840.X |
0.306 |
|
| 1985 |
Csernansky CA, Csernansky JG, Hollister LE. A comparison between centrifugation and filtration as a means to separate bound and unbound ligand during 3[H]-spiroperidol binding. Journal of Pharmacological Methods. 13: 187-91. PMID 3999754 DOI: 10.1016/0160-5402(85)90018-X |
0.427 |
|
| 1985 |
Csernansky JG, Csernansky CA, Glick SA, Hollister LE. Lidocaine kindling is accompanied by an increase in apomorphine stereotypy and mesolimbic dopamine D2 receptor density. Psychopharmacology Bulletin. 21: 707-11. PMID 2930865 |
0.372 |
|
| 1985 |
Csernansky JG, Kaplan J, Hollister LE. Problems in classification of schizophrenics as neuroleptic responders and nonresponders. The Journal of Nervous and Mental Disease. 173: 325-31. PMID 2860202 DOI: 10.1097/00005053-198506000-00001 |
0.482 |
|
| 1984 |
Kim DY, Hollister LE. Drug-refractory chronic schizophrenics: doses and plasma concentrations of thiothixene. Journal of Clinical Psychopharmacology. 4: 32-5. PMID 6693581 DOI: 10.1097/00004714-198402000-00005 |
0.344 |
|
| 1984 |
Henauer SA, Hollister LE. Cimetidine interaction with imipramine and nortriptyline. Clinical Pharmacology and Therapeutics. 35: 183-7. PMID 6692646 DOI: 10.1038/Clpt.1984.24 |
0.307 |
|
| 1984 |
Csernansky JG, Csernansky CA, Hollister LE. Distinct effects of two stresses on the behavioral response to apomorphine. Life Sciences. 35: 1513-8. PMID 6541282 DOI: 10.1016/0024-3205(84)90169-3 |
0.452 |
|
| 1984 |
Henauer S, Lombrozo L, Hollister LE. Circadian variations of lorazepam-induced neurologic deficits. Life Sciences. 35: 2193-7. PMID 6503609 DOI: 10.1016/0024-3205(84)90459-4 |
0.324 |
|
| 1984 |
Hollister LE, Yesavage J. Ergoloid mesylates for senile dementias: unanswered questions. Annals of Internal Medicine. 100: 894-8. PMID 6372566 DOI: 10.7326/0003-4819-100-6-894 |
0.349 |
|
| 1984 |
Csernansky JG, Lombrozo L, Gulevich GD, Hollister LE. Treatment of negative schizophrenic symptoms with alprazolam: a preliminary open-label study. Journal of Clinical Psychopharmacology. 4: 349-52. PMID 6150950 DOI: 10.1097/00004714-198412000-00013 |
0.529 |
|
| 1983 |
Nakano S, Hollister LE. Chronopharmacology of amitriptyline. Clinical Pharmacology and Therapeutics. 33: 453-9. PMID 6831823 DOI: 10.1097/00004714-198310000-00018 |
0.344 |
|
| 1983 |
Csernansky JG, Holman CA, Hollister LE. Variability and the dopamine hypothesis of schizophrenia. Schizophrenia Bulletin. 9: 325-8. PMID 6622990 DOI: 10.1093/Schbul/9.3.325 |
0.395 |
|
| 1983 |
Csernansky JG, Holman CA, Bonnet KA, Grabowsky K, King R, Hollister LE. Dopaminergic supersensitivity at distant sites following induced epileptic foci. Life Sciences. 32: 385-90. PMID 6402628 DOI: 10.1016/0024-3205(83)90084-X |
0.458 |
|
| 1983 |
Magliozzi JR, Kanter SL, Csernansky JG, Hollister LE. Detection of marijuana use in psychiatric patients by determination of urinary delta-9-tetrahydrocannabinol-11-oic acid. The Journal of Nervous and Mental Disease. 171: 246-9. PMID 6300320 DOI: 10.1097/00005053-198304000-00007 |
0.465 |
|
| 1983 |
Csernansky JG, Kaplan J, Holman CA, Hollister LE. Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients. Psychopharmacology. 81: 115-8. PMID 6138793 DOI: 10.1007/Bf00429003 |
0.47 |
|
| 1982 |
Hollister LE. Drug Interactions: A Source Book of Adverse Interactions, Their Mechanisms, Clinical Importance and Management Jama: the Journal of the American Medical Association. 247: 3361. DOI: 10.1001/Jama.1982.03320490057039 |
0.318 |
|
| 1981 |
Hollister LE. 'Second generation' antidepressant drugs. Psychosomatics. 22: 872-9. PMID 7031743 DOI: 10.1016/S0033-3182(81)73094-9 |
0.353 |
|
| 1981 |
Hollister LE, Conley FK, Britt RH, Shuer L. Long-term use of diazepam. Jama. 246: 1568-70. PMID 6792375 DOI: 10.1001/Jama.1981.03320140056031 |
0.303 |
|
| 1979 |
Hollister LE. Monitoring tricyclic antidepressant plasma concentrations. Jama. 241: 2530-3. PMID 439339 DOI: 10.1001/Jama.1979.03290490036022 |
0.311 |
|
| 1979 |
Yesavage JA, Tinklenberg JR, Hollister LE, Berger PA. Vasodilators in senile dementias: a review of the literature. Archives of General Psychiatry. 36: 220-3. PMID 420543 DOI: 10.1001/Archpsyc.1979.01780020110012 |
0.328 |
|
| 1979 |
Calil HM, Avery DH, Hollister LE, Creese I, Snyder SH. Serum levels of neuroleptics measured by dopamine radioreceptor assay and some clinical observations. Psychiatry Research. 1: 39-44. PMID 45128 DOI: 10.1016/0165-1781(79)90026-X |
0.335 |
|
| 1978 |
Nakano S, Hollister LE. No circadian effect on nortriptyline kinetics in man. Clinical Pharmacology and Therapeutics. 23: 199-203. PMID 620481 DOI: 10.1002/Cpt1978232199 |
0.323 |
|
| 1978 |
Davis KL, Hollister LE, Vento AL, Simonton S. Choline chloride in animal models of tardive dyskinesia. Life Sciences. 22: 1699-707. PMID 566830 DOI: 10.1016/0024-3205(78)90621-5 |
0.302 |
|
| 1978 |
Davis KL, Berger PA, Hollister LE, Defraites E. Physostigmine in mania. Archives of General Psychiatry. 35: 119-22. PMID 339869 DOI: 10.1001/Archpsyc.1978.01770250121012 |
0.304 |
|
| 1978 |
Nakano S, Gillespie HK, Hollister LE. Propranolol in experimentally induced stress. Psychopharmacology. 59: 279-84. PMID 32573 DOI: 10.1007/Bf00426635 |
0.326 |
|
| 1978 |
Nakano S, Hollister LE. Early clinical testing of antianxiety drugs: an experimental model. Progress in Neuro-Psychopharmacology. 2: 101-6. PMID 31642 DOI: 10.1016/0364-7722(78)90028-0 |
0.325 |
|
| 1978 |
Davis KL, Berger PA, Hollister LE, Barchas JD. Cholinergic involvement in mental disorders. Life Sciences. 22: 1865-71. PMID 27686 DOI: 10.1016/0024-3205(78)90472-1 |
0.301 |
|
| 1978 |
HOLLISTER LE. The Practitioner's Guide to Psychoactive Drugs American Journal of Psychiatry. 135: 516-a-516. DOI: 10.1176/Ajp.135.4.516-A |
0.318 |
|
| 1977 |
Hollister LE. Withdrawal from benzodiazepine therapy. Jama. 237: 1432. PMID 576627 DOI: 10.1001/Jama.1977.03270410032003 |
0.348 |
|
| 1976 |
Davis KL, Hollister LE, Barchas JD, Berger PA. Choline in tardive dyskinesia and Huntington's disease. Life Sciences. 19: 1507-15. PMID 136581 DOI: 10.1016/0024-3205(76)90095-3 |
0.306 |
|
| 1976 |
Hollister LE. Interactions of delta9-tetrahydrocannabinol with other drugs. Annals of the New York Academy of Sciences. 281: 212-8. PMID 14581 DOI: 10.1111/J.1749-6632.1976.Tb27932.X |
0.305 |
|
| 1976 |
Hollister LE. Cost of Drugs-Reply Jama: the Journal of the American Medical Association. 235: 2081. DOI: 10.1001/Jama.1976.03260450013012 |
0.325 |
|
| 1975 |
Hollister LE, Overall JE, Gerber ML. Marihuana and setting. Archives of General Psychiatry. 32: 798-801. PMID 1093507 DOI: 10.1001/Archpsyc.1975.01760240126010 |
0.32 |
|
| 1974 |
Hollister LE. Editorial: Psychotherapeutic drugs and driving. Annals of Internal Medicine. 80: 413. PMID 4816187 DOI: 10.7326/0003-4819-80-3-413_1 |
0.338 |
|
| 1974 |
Hollister LE, Prusmack JJ. Propranolol in withdrawal from opiates. Archives of General Psychiatry. 31: 695-8. PMID 4441241 DOI: 10.1001/Archpsyc.1974.01760170083013 |
0.368 |
|
| 1974 |
Hollister LE, Overall JE, Kimbell I, Pokorny A. Specific indications for different classes of phenothiazines. Archives of General Psychiatry. 30: 94-9. PMID 4148660 DOI: 10.1001/Archpsyc.1974.01760070072011 |
0.368 |
|
| 1973 |
Hollister LE. Uses of psychotherapeutic drugs. Annals of Internal Medicine. 79: 88-98. PMID 4721180 DOI: 10.7326/0003-4819-79-1-88 |
0.324 |
|
| 1973 |
Hollister LE, Tinklenberg JR. Subchronic oral doses of marihuana extract. Psychopharmacologia. 29: 247-52. PMID 4702276 DOI: 10.1007/Bf00414039 |
0.345 |
|
| 1973 |
Hollister LE. Human Pharmacology of Drugs of Abuse with Emphasis on Neuroendocrine Effects Progress in Brain Research. 39: 373-381. DOI: 10.1016/S0079-6123(08)64093-5 |
0.342 |
|
| 1972 |
Hollister LE. Clinical use of psychotherapeutic drugs. II. Antidepressant and antianxiety drugs and special problems in the use of psychotherapeutic drugs. Drugs. 4: 361-410. PMID 4569454 DOI: 10.2165/00003495-197204050-00002 |
0.332 |
|
| 1972 |
Hollister LE. Clinical use of psychotherapeutic drugs. I. Antipsychotic and antimanic drugs. Drugs. 4: 321-60. PMID 4568065 DOI: 10.2165/00003495-197204050-00001 |
0.344 |
|
| 1971 |
Hollister LE. Anxiety, depression and psychotropic drugs. Drugs. 1: 189-93. PMID 5123240 DOI: 10.2165/00003495-197101030-00001 |
0.306 |
|
| 1971 |
Hollister LE, Overall JE, Pokorny AD, Shelton J. Acetophenazine and diazepam in anxious depressions. Archives of General Psychiatry. 24: 273-8. PMID 5100621 DOI: 10.1001/Archpsyc.1971.01750090079012 |
0.314 |
|
| 1971 |
Hollister LE. Marihuana in man: three years later. Science (New York, N.Y.). 172: 21-9. PMID 4926514 DOI: 10.1126/Science.172.3978.21 |
0.33 |
|
| 1971 |
Klett CJ, Hollister LE, Caffey EM, Kaim SC. Evaluating changes in symptoms during acute alcohol withdrawal. Archives of General Psychiatry. 24: 174-8. PMID 4924290 DOI: 10.1001/Archpsyc.1971.01750080078013 |
0.3 |
|
| 1970 |
Hollister LE. Choice of antipsychotic drugs. The American Journal of Psychiatry. 127: 186-90. PMID 5528794 DOI: 10.1176/Ajp.127.2.186 |
0.363 |
|
| 1970 |
Hollister LE. Clinical use of psychotherapeutic drugs. Postgraduate Medicine. 47: 100-5. PMID 5413125 DOI: 10.1080/00325481.1970.11698099 |
0.37 |
|
| 1970 |
Hollister LE, Gillespie HK. Marihuana, ethanol, and dextroamphetamine. Mood and mental function alterations. Archives of General Psychiatry. 23: 199-203. PMID 4916451 DOI: 10.1001/Archpsyc.1970.01750030007002 |
0.306 |
|
| 1969 |
Overall JE, Hollister LE, Kimbell I, Shelton J. Extrinsic factors influencing responses to psychotherapeutic drugs. Archives of General Psychiatry. 21: 89-94. PMID 5815781 DOI: 10.1001/Archpsyc.1969.01740190091013 |
0.349 |
|
| 1968 |
Hollister LE, Richards RK, Gillespie HK. Comparison of tetra hydrocannabinol and synhexyl in man Clinical Pharmacology &Amp; Therapeutics. 9: 783-791. PMID 5721981 DOI: 10.1002/Cpt196896783 |
0.318 |
|
| 1967 |
Overall JE, Hollister LE, Dalal SN. Psychiatric drug research. Sample size requirements for one vs two raters. Archives of General Psychiatry. 16: 152-61. PMID 6019330 DOI: 10.1001/Archpsyc.1967.01730200020004 |
0.301 |
|
| 1967 |
Hollister LE, Overall JE, Shelton J, Pennington V, Kimbell I, Johnson M. Drug therapy of depression. Amitriptyline, perphenazine, and their combination in different syndromes. Archives of General Psychiatry. 17: 486-93. PMID 4861381 DOI: 10.1001/Archpsyc.1967.01730280102012 |
0.342 |
|
| 1965 |
HOLLISTER LE, OVERALL JE, BENNETT JL, KIMBELL I, SHELTON J. TRIPERIDOL IN NEWLY ADMITTED SCHIZOPHRENICS American Journal of Psychiatry. 122: 96-98. DOI: 10.1176/Ajp.122.1.96 |
0.351 |
|
| 1964 |
Hollister LE, Overall JE. Specific Value of Drugs in Psychiatric Illness Jama. 190. DOI: 10.1001/Jama.1964.03070190077028 |
0.326 |
|
| 1959 |
HOLLISTER LE, MARRAZZI AS, CASEY JF. SERUM OXIDASE ACTIVITY IN CHRONIC SCHIZOPHRENICS TREATED WITH TRANQUILIZING DRUGS American Journal of Psychiatry. 116: 553-554. DOI: 10.1176/Ajp.116.6.553 |
0.32 |
|
| Show low-probability matches. |